12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks experienced significant price movements. Gainers included MoonLake, INVO Bioscience, Femasys, Benitec Biopharma, SQZ Biotechnologies, and CollPlant Biotechnologies. Losers were Avalo Therapeutics, FibroGen, Surgalign Holdings, Nutriband, SCWorx, and Bio-Path Holdings.
June 26, 2023 | 1:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Benitec Biopharma shares increased by 35.77% to $0.27 during Monday's pre-market session, with a market cap of $7.5 million.
Benitec Biopharma's share price increased by 35.77% during the pre-market session, indicating a positive impact on the stock. The company's market cap of $7.5 million supports this assessment.
CONFIDENCE 90
IMPORTANCE 40
RELEVANCE 100
POSITIVE IMPACT
CollPlant Biotechnologies shares increased by 19.19% to $9.5 during Monday's pre-market session, with a market cap of $108.1 million.
CollPlant Biotechnologies' share price increased by 19.19% during the pre-market session, indicating a positive impact on the stock. The company's market cap of $108.1 million supports this assessment.
CONFIDENCE 90
IMPORTANCE 30
RELEVANCE 100
POSITIVE IMPACT
Femasys stock rose 36.63% to $0.84 during Monday's pre-market session, with a market cap of $11.0 million.
Femasys' share price increased by 36.63% during the pre-market session, indicating a positive impact on the stock. The company's market cap of $11.0 million supports this assessment.
CONFIDENCE 90
IMPORTANCE 40
RELEVANCE 100
POSITIVE IMPACT
INVO Bioscience shares rose 50.06% to $0.25 during Monday's pre-market session, with a market cap of $3.4 million.
INVO Bioscience's share price rose by 50.06% during the pre-market session, indicating a positive impact on the stock. The company's market cap of $3.4 million supports this assessment.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
MoonLake shares increased by 80.5% to $46.71 during Monday's pre-market session, with a market cap of $2.0 billion.
MoonLake's significant share price increase of 80.5% during the pre-market session indicates a strong positive impact on the stock. The company's market cap of $2.0 billion further supports this.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
SQZ Biotechnologies shares moved upwards by 30.29% to $0.52 during Monday's pre-market session, with a market cap of $15.3 million.
SQZ Biotechnologies' share price increased by 30.29% during the pre-market session, indicating a positive impact on the stock. The company's market cap of $15.3 million supports this assessment.
CONFIDENCE 90
IMPORTANCE 40
RELEVANCE 100
NEGATIVE IMPACT
Avalo Therapeutics shares fell 85.2% to $0.66 during Monday's pre-market session, with a market cap of $8.6 million.
Avalo Therapeutics' share price fell by 85.2% during the pre-market session, indicating a strong negative impact on the stock. The company's market cap of $8.6 million supports this assessment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Bio-Path Holdings stock declined by 13.15% to $1.85 during Monday's pre-market session, with a market cap of $14.7 million.
Bio-Path Holdings' share price declined by 13.15% during the pre-market session, indicating a negative impact on the stock. The company's market cap of $14.7 million supports this assessment.
CONFIDENCE 90
IMPORTANCE 20
RELEVANCE 100
NEGATIVE IMPACT
FibroGen shares declined by 78.2% to $3.5 during Monday's pre-market session, with a market cap of $341.5 million.
FibroGen's share price declined by 78.2% during the pre-market session, indicating a strong negative impact on the stock. The company's market cap of $341.5 million supports this assessment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Nutriband stock declined by 16.16% to $1.92 during Monday's pre-market session, with a market cap of $15.0 million.
Nutriband's share price declined by 16.16% during the pre-market session, indicating a negative impact on the stock. The company's market cap of $15.0 million supports this assessment.
CONFIDENCE 90
IMPORTANCE 20
RELEVANCE 100
NEGATIVE IMPACT
Surgalign Holdings stock decreased by 26.64% to $0.21 during Monday's pre-market session, with a market cap of $1.8 million.
Surgalign Holdings' share price decreased by 26.64% during the pre-market session, indicating a negative impact on the stock. The company's market cap of $1.8 million supports this assessment.
CONFIDENCE 90
IMPORTANCE 30
RELEVANCE 100
NEGATIVE IMPACT
SCWorx stock decreased by 14.31% to $0.45 during Monday's pre-market session, with a market cap of $5.8 million.
SCWorx's share price decreased by 14.31% during the pre-market session, indicating a negative impact on the stock. The company's market cap of $5.8 million supports this assessment.
CONFIDENCE 90
IMPORTANCE 20
RELEVANCE 100